24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Canditech
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:31
Fintech startup Sequence raises $7.5M to automate consumer and SMB finances
17:04
Redis has taken a default “yes” stance on AI tools
17:00
"If the S&P 500 drops 50%, not everyone will be able to handle it psychologically"
16:52
Full list of Israeli high-tech funding rounds in 2025
More stories
Buzz
Most popular
Daily
Weekly
1
Intel uncovers multi-million fraud scheme by ex-employee and supplier
2
Check Point acquires Israeli cyber startup Veriti in deal estimated at over $100 million
3
Startup baby boom on the way? Over 1,000 Israeli founders operating in stealth
4
"If the S&P 500 drops 50%, not everyone will be able to handle it psychologically"
5
“Despite disgusting descriptions of the IDF, the world still wants Israeli tech”: Lux’s Josh Wolfe on global demand for defense innovation
More news
Canditech
3 stories about Canditech
16 companies graduate from Meta’s first B2B Disruptors Program in Israel
10.08.22
|
James Spiro
The program, which ran for seven weeks, included strategic and practical content for early-stage B2B product-led startups
Canditech raises $9 million Seed round to help companies assess job candidates
16.06.22
|
Meir Orbach
The Israeli startup’s platform allows hiring managers to tailor simulations to their specific roles and at the same time, candidates are given the opportunity to "sample" the positions
Four Baby Startups That Prove Crisis Can Also Serve as an Opportunity
01.06.20
|
Maayan Manela
With many companies shutting down or cutting back on staff, Calclaist spoke to four entrepreneurs who decided to start a new business amid Covid-19